Differential Gene Expression Analysis of Major Macrophage and Fibroblast Subtypes in Lung Disease Related to Rheumatoid Arthritis

Overview

This study investigates the differential gene expression profiles of macrophage and fibroblast subtypes in rheumatoid arthritis-related interstitial lung disease (RA-ILD).

Background

Rheumatoid arthritis (RA) is a prevalent systemic autoimmune disease that significantly impacts health, particularly through extra-articular manifestations such as interstitial lung disease (ILD). RA-ILD is associated with increased morbidity and mortality.

Data Highlights

No numerical data or trial data was provided in the source material.

Key Findings

• RA-ILD occurs nine times more frequently in RA patients compared to matched controls.
• Up to 30% of RA patients exhibit radiographic evidence of early/subclinical ILD.
• Serum levels of specific proinflammatory and profibrotic mediators are associated with advanced forms of RA-ILD.
• Machine learning tools have identified protein mediators that distinguish RA-ILD from RA without ILD with high sensitivity and specificity.
• Application of single-cell RNA sequencing has revealed significant insights into macrophage-fibroblast interactions in lung disease.

Clinical Implications

Understanding the gene expression profiles of macrophages and fibroblasts in RA-ILD may aid in the identification of biomarkers for early detection and monitoring of disease progression.

Conclusion

The study highlights the investigation of cellular interactions in RA-ILD.

Related Resources & Content

1. Frontiers in Immunology, 2026 -- Editorial: Characterising the functional heterogeneity of synovial macrophages
2. Frontiers in Immunology, 2026 -- Metagenomic Characterization of Gut Microbiota in Rheumatoid Arthritis-Associated Interstitial Lung Disease: Taxonomic Shifts and Clinical Correlations
3. Clinical Rheumatology -- Investigation of the Differential Proteome in Human Synovial Fibroblasts from Arthritis Patients
4. New ACR Guideline Summaries: Screen, Monitor and Treat ILD | American College of Rheumatology
5. Clinical Rheumatology — Identification of ferroptosis hub gene cDKN1A relating to immune microenvironment in rheumatoid arthritis via bioinformatic analysis and experimental verification
6. New ACR Guideline Summaries: Screen, Monitor and Treat ILD | American College of Rheumatology
7. Checking your browser - reCAPTCHA
8. Efficacy and safety of rituximab in rheumatoid arthritis-associated interstitial lung disease: a systematic review and meta-analysis - PubMed